FORM & FACT US · USD
form&fact
United States · USD
購入対象市場

米国カタログ・USD。表示言語を変えても商品は変わらず、現地での購入可否を保証しません。

戻る

Balance One

Probiotic

プロバイオティクス錠剤60 Tablet(s)

1回分の量: 1 Tablet(s)

比較 (0/3)

NIH label entry date: 2020-08-23 · NIH DSLD · historical label

原文ラベル(英語)

Probiotic

UPC/SKU: X001S1TCI7

過去に記録したラベルです。現在の包装をご確認ください。現行処方や実際の内容物は独立検証していません。

表示されている成分

原文ラベル(英語)

表示されている成分
表示されている成分ラベル上の1回分の成分量% Daily Value
Sodium5 mg / 1 Tablet(s)< 1% Adults and children 4 or more years of age
Proprietary Probiotic Blend: Note: 15 Billion CFU%at time of manufacture. Minimum of 5 billion CFU at expiration.0 NP / 1 Tablet(s)Adults and children 4 or more years of age Daily Value (DV) Not Established
Proprietary Probiotic Blend: Note: 15 Billion CFU%at time of manufacture. Minimum of 5 billion CFU at expiration. > L. plantarum0 NP / 1 Tablet(s)—
Proprietary Probiotic Blend: Note: 15 Billion CFU%at time of manufacture. Minimum of 5 billion CFU at expiration. > L. paracasei0 NP / 1 Tablet(s)—
Proprietary Probiotic Blend: Note: 15 Billion CFU%at time of manufacture. Minimum of 5 billion CFU at expiration. > L. acidophilus0 NP / 1 Tablet(s)—
Proprietary Probiotic Blend: Note: 15 Billion CFU%at time of manufacture. Minimum of 5 billion CFU at expiration. > L. casei0 NP / 1 Tablet(s)—
Proprietary Probiotic Blend: Note: 15 Billion CFU%at time of manufacture. Minimum of 5 billion CFU at expiration. > B. longum0 NP / 1 Tablet(s)—
Proprietary Probiotic Blend: Note: 15 Billion CFU%at time of manufacture. Minimum of 5 billion CFU at expiration. > B. breve0 NP / 1 Tablet(s)—
Proprietary Probiotic Blend: Note: 15 Billion CFU%at time of manufacture. Minimum of 5 billion CFU at expiration. > B. infantis0 NP / 1 Tablet(s)—
Proprietary Probiotic Blend: Note: 15 Billion CFU%at time of manufacture. Minimum of 5 billion CFU at expiration. > L. brevis0 NP / 1 Tablet(s)—
Proprietary Probiotic Blend: Note: 15 Billion CFU%at time of manufacture. Minimum of 5 billion CFU at expiration. > L. salivarius0 NP / 1 Tablet(s)—
Proprietary Probiotic Blend: Note: 15 Billion CFU%at time of manufacture. Minimum of 5 billion CFU at expiration. > L. rhamnosus0 NP / 1 Tablet(s)—
Proprietary Probiotic Blend: Note: 15 Billion CFU%at time of manufacture. Minimum of 5 billion CFU at expiration. > Lactococcus lactis0 NP / 1 Tablet(s)—
Proprietary Probiotic Blend: Note: 15 Billion CFU%at time of manufacture. Minimum of 5 billion CFU at expiration. > S. thermophilus0 NP / 1 Tablet(s)—
Prebiotic Fructooligosaccharides25 mg / 1 Tablet(s)Adults and children 4 or more years of age Daily Value (DV) Not Established

Label version: dsld:233377. Amounts include their declared serving basis; nested components retain their parent path. This is not a verified current retail product. Source market flag: on-market (source flag only).

出典: NIH DSLD ↗

1回分、成分形態、単位を区別してください。不明な量をゼロとは扱いません。 似た成分名は自動的に統合しません。混合物の総量には内訳の成分が含まれる場合があるため、足し合わせないでください。

訂正・お問い合わせ →

成分コストを計算

過去に記録したラベルです。現在の包装をご確認ください。現行処方や実際の内容物は独立検証していません。

比較